First Trust Nasdaq Pharmaceuticals ETF

FTXH

First Trust

First Trust Nasdaq Pharmaceuticals ETF (FTXH) on the Akinda fund screen (AAOIFI-derived): Not halal. Coverage 99.85%. Below: the fund under all five rulebooks, its facts and every holding with its own verdict.

Akinda fund screen

Akinda fund screen (AAOIFI-derived)Not halalCoverage: 99.85%

Halal 68.00%
Doubtful 0.00%
Not halal 31.85%
Not rated 0.15%

The bar is scaled to fit; the figures are as reported, and the buckets do not always total 100%.

Coverage is the share of the fund's weight we hold a usable verdict for. Below 95%, a fund is rated only when the weight we can see already breaches the 5% limit; otherwise it is not rated by this method.

Fund facts

Issuer: First Trust
Venue (where it trades): United States
Domicile (where it is registered): United States
Reporting currency: USD
Expense ratio: 0.60%
AUM: 1.18B USD
Holdings: 50 (50 screened)
Basket as of (provider): 3 Nov 2026
Basket fetched by Akinda: 3 Nov 2026
Verdict updated: 3 Nov 2026

Venue is where a fund trades; domicile is where it is registered. London-listed funds are domiciled in Ireland or Luxembourg, so use Venue for UK ETFs.

Five rulebooks

Rulebook	Verdict	Halal	Not halal
Akinda fund screen (AAOIFI)	Not halal	68.00%	31.85%
DJIM	Not halal	67.93%	29.59%
FTSE	Not halal	30.16%	67.86%
MSCI	Not halal	30.16%	67.86%
S&P	Not halal	67.93%	29.59%

Every bar uses the same 0–100% scale. Index rulebooks report only halal and not-halal weight; uncoloured weight is weight that rulebook does not classify. Coverage is published for the Akinda fund screen only.

The fund screen and the four index rulebooks answer different questions, so they are expected to disagree. A fund can be doubtful on our fund screen and halal under S&P; both are correct.

Holdings

1–50 of 50 holdings, largest first · basket as of 3 Nov 2026

No.	Holding	Weight	Akinda (AAOIFI)	DJIM	FTSE	MSCI	S&P
No.	Holding	Weight	Akinda (AAOIFI)	DJIM	FTSE	MSCI	S&P
1	LLYEli Lilly and Company	8.22%	Halal	Halal	Not halal	Not halal	Halal
2	ABBVAbbVie Inc.	7.71%	Halal	Halal	Not halal	Not halal	Halal
3	PFEPfizer Inc.	7.19%	Not halal	Not halal	Halal	Halal	Not halal
4	JNJJohnson & Johnson	6.89%	Halal	Halal	Halal	Halal	Halal
5	MRKMerck & Co., Inc.	6.78%	Halal	Halal	Not halal	Not halal	Halal
6	BIIBBiogen Inc.	3.92%	Halal	Halal	Halal	Halal	Halal
7	GILDGilead Sciences, Inc.	3.91%	Halal	Halal	Not halal	Not halal	Halal
8	REGNRegeneron Pharmaceuticals, Inc.	3.89%	Halal	Halal	Halal	Halal	Halal
9	VTRSViatris Inc.	3.86%	Not halal	Not halal	Not halal	Not halal	Not halal
10	AMGNAmgen Inc.	3.63%	Not halal	Not halal	Not halal	Not halal	Not halal
11	UTHRUnited Therapeutics Corporation	3.49%	Not halal	Not halal	Not halal	Not halal	Not halal
12	ZTSZoetis Inc.	3.47%	Halal	Halal	Not halal	Not halal	Halal
13	VRTXVertex Pharmaceuticals Incorporated	3.44%	Halal	Halal	Halal	Halal	Halal
14	INCYIncyte Corporation	3.24%	Halal	Halal	Not halal	Not halal	Halal
15	BMYBristol-Myers Squibb Company	3.13%	Not halal	Not halal	Not halal	Not halal	Not halal
16	EXELExelixis, Inc.	2.59%	Halal	Halal	Not halal	Not halal	Halal
17	JAZZJazz Pharmaceuticals Plc	2.30%	Not halal	Not halal	Not halal	Not halal	Not halal
18	ILMNIllumina, Inc.	1.83%	Halal	Not rated	Not rated	Not rated	Not rated
19	HALOHalozyme Therapeutics, Inc.	1.76%	Not halal	Halal	Not halal	Not halal	Halal
20	MEDPMedpace Holdings, Inc.	1.51%	Halal	Halal	Halal	Halal	Halal
21	CRLCharles River Laboratories International, Inc.	1.17%	Halal	Halal	Not halal	Not halal	Halal
22	NBIXNeurocrine Biosciences, Inc.	1.16%	Halal	Halal	Halal	Halal	Halal
23	BMRNBioMarin Pharmaceutical Inc.	1.15%	Halal	Halal	Halal	Halal	Halal
24	ELANElanco Animal Health Incorporated	1.11%	Not halal	Not halal	Not halal	Not halal	Not halal
25	ALNYAlnylam Pharmaceuticals, Inc.	0.79%	Halal	Halal	Not halal	Not halal	Halal
26	MRNAModerna, Inc.	0.74%	Not halal	Not halal	Not halal	Not halal	Not halal
27	CAICaris Life Sciences, Inc.	0.63%	Halal	Halal	Not halal	Not halal	Halal
28	AMRXAmneal Pharmaceuticals, Inc.	0.57%	Not halal	Not halal	Not halal	Not halal	Not halal
29	LGNDLigand Pharmaceuticals Inc. (Class B)	0.53%	Halal	Halal	Not halal	Not halal	Halal
30	TGTXTG Therapeutics, Inc.	0.53%	Halal	Halal	Halal	Halal	Halal
31	GHGuardant Health, Inc.	0.52%	Halal	Halal	Not halal	Not halal	Halal
32	TXG10X Genomics, Inc. (Class A)	0.52%	Halal	Halal	Not halal	Not halal	Halal
33	TWSTTwist Bioscience Corporation	0.51%	Halal	Halal	Not halal	Not halal	Halal
34	SYRESpyre Therapeutics, Inc.	0.50%	Not halal	Not halal	Not halal	Not halal	Not halal
35	ADPTAdaptive Biotechnologies Corporation	0.50%	Halal	Halal	Not halal	Not halal	Halal
36	KYMRKymera Therapeutics, Inc.	0.50%	Not halal	Not rated	Not halal	Not halal	Not rated
37	ROIVRoivant Sciences Ltd.	0.50%	Not halal	Not halal	Not halal	Not halal	Not halal
38	ORKAOruka Therapeutics, Inc.	0.49%	Not halal	Not halal	Not halal	Not halal	Not halal
39	IOVAIovance Biotherapeutics, Inc.	0.48%	Halal	Halal	Halal	Halal	Halal
40	TNGXTango Therapeutics, Inc.	0.46%	Not halal	Not halal	Not halal	Not halal	Not halal
41	PTGXProtagonist Therapeutics, Inc.	0.46%	Not halal	Not halal	Not halal	Not halal	Not halal
42	ALKSAlkermes Plc	0.45%	Halal	Halal	Not halal	Not halal	Halal
43	KRYSKrystal Biotech, Inc.	0.43%	Not halal	Not halal	Not halal	Not halal	Not halal
44	DNTHDianthus Therapeutics, Inc.	0.36%	Not halal	Not halal	Not halal	Not halal	Not halal
45	ELVNEnliven Therapeutics Inc.	0.36%	Not halal	Not halal	Not halal	Not halal	Not halal
46	TVTXTravere Therapeutics, Inc.	0.35%	Halal	Halal	Not halal	Not halal	Halal
47	ARWRArrowhead Pharmaceuticals, Inc.	0.34%	Halal	Halal	Not halal	Not halal	Halal
48	CORTCorcept Therapeutics Inc.	0.33%	Halal	Halal	Not halal	Not halal	Halal
49	ACADACADIA Pharmaceuticals Inc.	0.33%	Halal	Halal	Not halal	Not halal	Halal
50	LQDALiquidia Technologies, Inc.	0.31%	Halal	Halal	Not halal	Not halal	Halal

Not rated means we hold no usable verdict for that company; it is never treated as compliant.

How Akinda screens funds and stocks